Occam Places Wildon Farwell as CMO of Dyne
Dyne Therapeutics, an Atlas Investment, is a platform biotech developing therapeutics across neuromuscular indications.
In early 2021, Occam recruited Wildon Farwell, MD as the company’s CMO. Previously, Wildon held a lengthy career at Biogen, having most recently served as the company’s Global Medical Head for Neuromuscular Diseases.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.